Status:
RECRUITING
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Lead Sponsor:
Konkuk University Medical Center
Conditions:
Emergence Delirium
Strabismus
Eligibility:
All Genders
4-7 years
Phase:
PHASE4
Brief Summary
The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine
Detailed Description
EA is one of the most common postoperative complications in after general anesthesia in pre-school aged pediatric patients. There are several causes contributed to occurrence of EA such as postoperati...
Eligibility Criteria
Inclusion
- Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3.
Exclusion
- ASA classification 3 or more
- impaired liver function
- impaired kidney function
- myasthenia gravis or other neuromuscular disorders
- history of drug allergy
- cardiovascular disease or arrhythmia
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2025
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06035757
Start Date
December 1 2023
End Date
August 15 2025
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, Seoul-T'ǔkpyǒlshi, South Korea, 05030